162 related articles for article (PubMed ID: 33184290)
1. DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity.
Cui D; Dai X; Gong L; Chen X; Wang L; Xiong X; Zhao Y
Cell Death Dis; 2020 Nov; 11(11):976. PubMed ID: 33184290
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
3. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
4. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
7. DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
Gong L; Shu J; Chen X; Pan H; Chen G; Bi Y; Cui D; Li X; Liu D; Wang L; Wang Y; Liu P; Xiong X; Zhao Y
Cancer Lett; 2021 Oct; 519():263-276. PubMed ID: 34320372
[TBL] [Abstract][Full Text] [Related]
8. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
9. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
[TBL] [Abstract][Full Text] [Related]
10. DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells.
Bi Y; Chen X; Wei B; Wang L; Gong L; Li H; Xiong X; Zhao Y
Theranostics; 2021; 11(13):6355-6369. PubMed ID: 33995662
[No Abstract] [Full Text] [Related]
11. INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4.
Liu YY; Tanikawa C; Ueda K; Matsuda K
Int J Oncol; 2019 Jun; 54(6):1907-1920. PubMed ID: 31081062
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human mTOR complexes by DEPTOR.
Wälchli M; Berneiser K; Mangia F; Imseng S; Craigie LM; Stuttfeld E; Hall MN; Maier T
Elife; 2021 Sep; 10():. PubMed ID: 34519268
[TBL] [Abstract][Full Text] [Related]
13. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.
Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB
Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743
[TBL] [Abstract][Full Text] [Related]
14. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis.
Xiong X; Liu X; Li H; He H; Sun Y; Zhao Y
Cell Death Dis; 2018 Nov; 9(11):1131. PubMed ID: 30425236
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
17. Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.
Chao T; Zhou X; Cao B; Liao P; Liu H; Chen Y; Park HW; Zeng SX; Lu H
Nat Commun; 2016 Dec; 7():13755. PubMed ID: 28008906
[TBL] [Abstract][Full Text] [Related]
18. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.
Farkas C; Martins CP; Escobar D; Hepp MI; Castro AF; Evan G; Gutiérrez JL; Warren R; Donner DB; Pincheira R
PLoS One; 2013; 8(9):e73817. PubMed ID: 24040083
[TBL] [Abstract][Full Text] [Related]
19. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.
Chen X; Xiong X; Cui D; Yang F; Wei D; Li H; Shu J; Bi Y; Dai X; Gong L; Sun Y; Zhao Y
Oncogene; 2020 Feb; 39(7):1557-1571. PubMed ID: 31685947
[TBL] [Abstract][Full Text] [Related]
20. DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis.
Chen S; Jia L; Zhang S; Zheng Y; Zhou Y
Stem Cell Res Ther; 2018 Jul; 9(1):185. PubMed ID: 29973283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]